Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)

ClinicalTrials.gov ID: NCT00067093

Public ClinicalTrials.gov record NCT00067093. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00067093
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,452 participants

Conditions and interventions

Interventions

  • SanOrg34006 Drug
  • LMW heparin Drug
  • Unfractionated heparin Drug
  • Vitamin K antagonist (VKA) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
Aug 31, 2005
Completion
Aug 31, 2005
Last update posted
Apr 5, 2011

2003 – 2005

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
University of Colorado Health Sciences Center Denver Colorado 80129
Jackson Cardio-Vascular Clinic Jacksonville Florida 32216
MIMA Century Research Associates Melbourne Florida 32901
Medical College of Georgia Augusta Georgia 30912
DeKalb Medical Center Decatur Georgia 30033-6136
Northwestern University Chicago Illinois 60611
Evanston Northwestern Healthcare Evanston Illinois 60201
Loyola University of Chicago Maywood Illinois 60513
Consultants in Pulmonary Medicine Olathe Kansas 66061
Boston Medical Center Boston Massachusetts 02118
St. Joseph Mercy - Oakland Research Center Pontiac Michigan 48341
Lovelace Health Systems Albuquerque New Mexico 87108
North Shore University Hospital Manhasset New York 11030
University of Rochester Medical Center Rochester New York 14642
Health System Research Center Grand Forks North Dakota 58201
University of Oklahoma HSC Oklahoma City Oklahoma 73104
Lehigh Valley Hospital Allentown Pennsylvania 18103
James Muntz Houston Texas 77030
Scott and White Memorial Hospital & Clinic Temple Texas 76508
Inova Alexandria Hospital Alexandria Virginia 22304
Pulmonary Associates Fredericksburg Virginia 22401
McGuire VAMC Richmond Virginia 23249
Swedish Medical Center Seattle Washington 98122
William Dittman Spokane Washington 99203

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00067093, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2011 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00067093 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →